Drug Trial Radar · NCT05957380
Clinical Study to Evaluate the Efficacy and Safety of DA-2803 in Chronic Hepatitis B Patients
Last checked: Nov 20, 2026Latest source record: Oct 23, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
120
Actual
Start
Mar 20, 2023
Primary completion
Sep 30, 2024
Study completion Sep 30, 2024
Sponsor
- Lead sponsor
- Dong-A ST Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Jul 24, 2023
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 19 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is a multi-center, double-blind, active-controlled, randomized, parallel clinical study to evaluate the efficacy and safety of DA-2803 in chronic hepatitis B subjects
Conditions
- Hepatitis B
Interventions
DA-2803Drug
All participants are administered one tablet per day for 48 weeks
DA-2803-RDrug
All participants are administered one tablet per day for 48 weeks
Placebo of DA-2803Drug
All participants are administered one tablet per day for 48 weeks
Placebo of DA-2803-RDrug
All participants are administered one tablet per day for 48 weeks
Primary outcomes
What the sponsor says the trial is designed to measure.
- HBV DNA(log10 IU/mL) changeTime frame: 48 weeks
Locations
1 site in 1 country. Site status is shown where the registry gives one.
The Catholic University of Korea, Seoul
Seoul, South Korea
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.